COMP <GO>
BHC vs MRK // ENTERPRISE SCALE & MARKET CAP
Bausch Health Companies Inc. (NYSE) VS. Merck & Company Inc. Common Stock (new) (NYSE) • 15-METRIC TALLY: BHC 6
— MRK 9
▲ ENTERPRISE SCALE & MARKET CAP LEADER: MRK
LAST: $8.20 (-7.97%) • MKT CAP: $3.33B
market-cap
$3.33B
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
market-cap
$361.02B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BHC VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BHC | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 74.80% | -33.80 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 7.60% | 20.70% | -13.10 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 10.5x | 15.3x | -4.80 | BHC | /valuation <GO> |
| Free Cash Flow Yield | 22.00% | 3.42% | +18.58 | BHC | /fcf-yield <GO> |
| Operating Margin | 17.70% | 34.30% | -16.60 | MRK | /operating-margins <GO> |
| Net Profit Margin | 1.50% | 28.10% | -26.60 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 6.70% | 1.30% | +5.40 | BHC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.45 | 5.19 | -4.74 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | BHC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.80% | 6.60% | +0.20 | MRK | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 72.3 | 56.9 | +15.44 | BHC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.97 | 0.92 | +0.05 | BHC | /macro-sensitivity <GO> |
| Forward P/E Multiple | 19.7x | 18.4x | +1.30 | MRK | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $3.33B | $361.02B | -$357.69B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BHC REV | MRK REV | BHC GROSS % | MRK GROSS % | BHC FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $10.27B | $65.01B | 44.0% | 74.8% | $1.00B | $12.36B |
| FY 2024 | $9.63B | $64.17B | 44.0% | 76.3% | $1.26B | $18.10B |
| FY 2023 | $8.76B | $60.12B | 44.0% | 44.0% | $637.9M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BHC // BETA 0.97
MRK // BETA 0.92